Loading…
CNS myelinogenesis in vitro: Myelin basic protein deficient shiverer oligodendrocytes
The shiverer mutant mouse is an autosomal recessive mutant characterized by incomplete myelin sheath formation in the central nervous system (CNS). Such mice contain a deletion in the MBP gene, do not produce MBP proteins, and have little or no compact myelin in the CNS. To investigate the myelin sh...
Saved in:
Published in: | Journal of neuroscience research 2002-08, Vol.69 (3), p.305-317 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c4561-185d4c901573b98f865ec2b2a0743780fb3105948bc742af305846f5a0770ffa3 |
---|---|
cites | cdi_FETCH-LOGICAL-c4561-185d4c901573b98f865ec2b2a0743780fb3105948bc742af305846f5a0770ffa3 |
container_end_page | 317 |
container_issue | 3 |
container_start_page | 305 |
container_title | Journal of neuroscience research |
container_volume | 69 |
creator | Seiwa, Chika Kojima-Aikawa, Kyoko Matsumoto, Isamu Asou, Hiroaki |
description | The shiverer mutant mouse is an autosomal recessive mutant characterized by incomplete myelin sheath formation in the central nervous system (CNS). Such mice contain a deletion in the MBP gene, do not produce MBP proteins, and have little or no compact myelin in the CNS. To investigate the myelin sheath formation in shiverer mutant mice resulting from the absence of compact myelin, firstly we developed new methods for generating oligodendrocyte precursor cells (OPCs) from an E17 mouse brain, and examined homozygous shiverer (shi/shi) OPCs with respect to myelinogenesis in vitro. After treatment of shi/shi OPCs in vitro with PDGF or bFGF, proliferation of shi/shi OPCs was enhanced similar to that observed in wild‐type OPCs. The majority of cells from the shiverer mutant mouse, however, remained as A2B5‐immunoreactive early OPCs. To determine which molecular events affect the differentiation of shi/shi OPCs, we determined the signaling pathway that could be responsible for activating myelin sheath‐specific proteins. We found that the developmental schedule of shi/shi OPCs in vitro was accelerated by the addition of cyclic AMP analogs, dibutyryl cAMP (dbcAMP). Treatment of shi/shi OPCs with dbcAMP had significant effect on the differentiation of OPCs that became MAG‐expressing oligodendrocytes. To further determine the possible mechanism involved in the activation of MAG by dbcAMP, we examined the cAMP‐dependent signaling cascades. The activation of JNK was markedly stimulated by treatment with dbcAMP, and the phosphorylation of transcription factor ATF‐2 was also stimulated by dbcAMP. We demonstrated that the MAG‐positive shi/shi oligodendrocytes extend processes around axons and finally covered the axon, this was clearly observed by immunocytochemistry of shi/shi oligodendrocyte‐DRG cocultures. These results suggest that ATF‐2 coupled to specific signal transduction cascades plays an important regulatory role in MAG expression at a specific stage of shi/shi oligodendrocyte differentiation, and OPCs grow to become myelin‐forming cells with numerous cell processes that wraps around an axon to form a thin myelin sheath. © 2002 Wiley‐Liss, Inc. |
doi_str_mv | 10.1002/jnr.10291 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71927586</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>71927586</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4561-185d4c901573b98f865ec2b2a0743780fb3105948bc742af305846f5a0770ffa3</originalsourceid><addsrcrecordid>eNqFkM1P3DAQxa0KVBbaA_8Aygmph8D4K465wQJbPrqV2gJHK3HGYMgm1M5C97-vyy7lVPU0M3q_eXp6hGxT2KMAbP--C2lhmr4jIwpa5UIKtUZGwAvIBVC2QTZjvAcArSV_TzYoo0yCYiNyNZ5-z2YLbH3X32KH0cfMd9mTH0J_kH15EbK6it5mj6EfMF0NOm89dkMW7_wTBgxZ3_rbvsGuCb1dDBg_kHVXtRE_ruYWuTo9-TH-nF9-nZyNDy9zK2RBc1rKRlgNVCpe69KVhUTLalaBElyV4GpOQWpR1lYJVjkOshSFk0lX4FzFt8ju0jdl-znHOJiZjxbbtuqwn0ejqGZKlsV_QVoWIFOkBH5agjb0MQZ05jH4WRUWhoL5U7ZJZZuXshO7szKd1zNs3shVuwnYXwLPvsXFv53M-fTbq2W-_PBxwF9_P6rwYArFlTQ304kBdnw9OdJH5oL_Bnmel0U</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>18605561</pqid></control><display><type>article</type><title>CNS myelinogenesis in vitro: Myelin basic protein deficient shiverer oligodendrocytes</title><source>Wiley-Blackwell Read & Publish Collection</source><creator>Seiwa, Chika ; Kojima-Aikawa, Kyoko ; Matsumoto, Isamu ; Asou, Hiroaki</creator><creatorcontrib>Seiwa, Chika ; Kojima-Aikawa, Kyoko ; Matsumoto, Isamu ; Asou, Hiroaki</creatorcontrib><description>The shiverer mutant mouse is an autosomal recessive mutant characterized by incomplete myelin sheath formation in the central nervous system (CNS). Such mice contain a deletion in the MBP gene, do not produce MBP proteins, and have little or no compact myelin in the CNS. To investigate the myelin sheath formation in shiverer mutant mice resulting from the absence of compact myelin, firstly we developed new methods for generating oligodendrocyte precursor cells (OPCs) from an E17 mouse brain, and examined homozygous shiverer (shi/shi) OPCs with respect to myelinogenesis in vitro. After treatment of shi/shi OPCs in vitro with PDGF or bFGF, proliferation of shi/shi OPCs was enhanced similar to that observed in wild‐type OPCs. The majority of cells from the shiverer mutant mouse, however, remained as A2B5‐immunoreactive early OPCs. To determine which molecular events affect the differentiation of shi/shi OPCs, we determined the signaling pathway that could be responsible for activating myelin sheath‐specific proteins. We found that the developmental schedule of shi/shi OPCs in vitro was accelerated by the addition of cyclic AMP analogs, dibutyryl cAMP (dbcAMP). Treatment of shi/shi OPCs with dbcAMP had significant effect on the differentiation of OPCs that became MAG‐expressing oligodendrocytes. To further determine the possible mechanism involved in the activation of MAG by dbcAMP, we examined the cAMP‐dependent signaling cascades. The activation of JNK was markedly stimulated by treatment with dbcAMP, and the phosphorylation of transcription factor ATF‐2 was also stimulated by dbcAMP. We demonstrated that the MAG‐positive shi/shi oligodendrocytes extend processes around axons and finally covered the axon, this was clearly observed by immunocytochemistry of shi/shi oligodendrocyte‐DRG cocultures. These results suggest that ATF‐2 coupled to specific signal transduction cascades plays an important regulatory role in MAG expression at a specific stage of shi/shi oligodendrocyte differentiation, and OPCs grow to become myelin‐forming cells with numerous cell processes that wraps around an axon to form a thin myelin sheath. © 2002 Wiley‐Liss, Inc.</description><identifier>ISSN: 0360-4012</identifier><identifier>EISSN: 1097-4547</identifier><identifier>DOI: 10.1002/jnr.10291</identifier><identifier>PMID: 12125072</identifier><language>eng</language><publisher>New York: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Activating Transcription Factor 2 ; Animals ; Axons - metabolism ; Cell Differentiation ; Central Nervous System - growth & development ; Coculture Techniques ; cyclic AMP ; Cyclic AMP - metabolism ; Cyclic AMP - pharmacology ; Cyclic AMP Response Element-Binding Protein - metabolism ; differentiation ; Female ; Fibroblast Growth Factor 2 - pharmacology ; Ganglia, Spinal - growth & development ; Ganglia, Spinal - metabolism ; Immunoblotting ; Immunohistochemistry ; Male ; Mice ; Mice, Inbred C57BL ; Mice, Neurologic Mutants ; Myelin Basic Protein - genetics ; Myelin Sheath - metabolism ; myelin-associated glycoprotein ; Myelin-Associated Glycoprotein - metabolism ; Oligodendroglia - metabolism ; Platelet-Derived Growth Factor - pharmacology ; Reverse Transcriptase Polymerase Chain Reaction ; shiverer oligodendrocyte ; Signal Transduction ; transcription factor ATF-2 ; Transcription Factors - metabolism</subject><ispartof>Journal of neuroscience research, 2002-08, Vol.69 (3), p.305-317</ispartof><rights>Copyright © 2002 Wiley‐Liss, Inc.</rights><rights>Copyright 2002 Wiley-Liss, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4561-185d4c901573b98f865ec2b2a0743780fb3105948bc742af305846f5a0770ffa3</citedby><cites>FETCH-LOGICAL-c4561-185d4c901573b98f865ec2b2a0743780fb3105948bc742af305846f5a0770ffa3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12125072$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Seiwa, Chika</creatorcontrib><creatorcontrib>Kojima-Aikawa, Kyoko</creatorcontrib><creatorcontrib>Matsumoto, Isamu</creatorcontrib><creatorcontrib>Asou, Hiroaki</creatorcontrib><title>CNS myelinogenesis in vitro: Myelin basic protein deficient shiverer oligodendrocytes</title><title>Journal of neuroscience research</title><addtitle>J. Neurosci. Res</addtitle><description>The shiverer mutant mouse is an autosomal recessive mutant characterized by incomplete myelin sheath formation in the central nervous system (CNS). Such mice contain a deletion in the MBP gene, do not produce MBP proteins, and have little or no compact myelin in the CNS. To investigate the myelin sheath formation in shiverer mutant mice resulting from the absence of compact myelin, firstly we developed new methods for generating oligodendrocyte precursor cells (OPCs) from an E17 mouse brain, and examined homozygous shiverer (shi/shi) OPCs with respect to myelinogenesis in vitro. After treatment of shi/shi OPCs in vitro with PDGF or bFGF, proliferation of shi/shi OPCs was enhanced similar to that observed in wild‐type OPCs. The majority of cells from the shiverer mutant mouse, however, remained as A2B5‐immunoreactive early OPCs. To determine which molecular events affect the differentiation of shi/shi OPCs, we determined the signaling pathway that could be responsible for activating myelin sheath‐specific proteins. We found that the developmental schedule of shi/shi OPCs in vitro was accelerated by the addition of cyclic AMP analogs, dibutyryl cAMP (dbcAMP). Treatment of shi/shi OPCs with dbcAMP had significant effect on the differentiation of OPCs that became MAG‐expressing oligodendrocytes. To further determine the possible mechanism involved in the activation of MAG by dbcAMP, we examined the cAMP‐dependent signaling cascades. The activation of JNK was markedly stimulated by treatment with dbcAMP, and the phosphorylation of transcription factor ATF‐2 was also stimulated by dbcAMP. We demonstrated that the MAG‐positive shi/shi oligodendrocytes extend processes around axons and finally covered the axon, this was clearly observed by immunocytochemistry of shi/shi oligodendrocyte‐DRG cocultures. These results suggest that ATF‐2 coupled to specific signal transduction cascades plays an important regulatory role in MAG expression at a specific stage of shi/shi oligodendrocyte differentiation, and OPCs grow to become myelin‐forming cells with numerous cell processes that wraps around an axon to form a thin myelin sheath. © 2002 Wiley‐Liss, Inc.</description><subject>Activating Transcription Factor 2</subject><subject>Animals</subject><subject>Axons - metabolism</subject><subject>Cell Differentiation</subject><subject>Central Nervous System - growth & development</subject><subject>Coculture Techniques</subject><subject>cyclic AMP</subject><subject>Cyclic AMP - metabolism</subject><subject>Cyclic AMP - pharmacology</subject><subject>Cyclic AMP Response Element-Binding Protein - metabolism</subject><subject>differentiation</subject><subject>Female</subject><subject>Fibroblast Growth Factor 2 - pharmacology</subject><subject>Ganglia, Spinal - growth & development</subject><subject>Ganglia, Spinal - metabolism</subject><subject>Immunoblotting</subject><subject>Immunohistochemistry</subject><subject>Male</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Mice, Neurologic Mutants</subject><subject>Myelin Basic Protein - genetics</subject><subject>Myelin Sheath - metabolism</subject><subject>myelin-associated glycoprotein</subject><subject>Myelin-Associated Glycoprotein - metabolism</subject><subject>Oligodendroglia - metabolism</subject><subject>Platelet-Derived Growth Factor - pharmacology</subject><subject>Reverse Transcriptase Polymerase Chain Reaction</subject><subject>shiverer oligodendrocyte</subject><subject>Signal Transduction</subject><subject>transcription factor ATF-2</subject><subject>Transcription Factors - metabolism</subject><issn>0360-4012</issn><issn>1097-4547</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><recordid>eNqFkM1P3DAQxa0KVBbaA_8Aygmph8D4K465wQJbPrqV2gJHK3HGYMgm1M5C97-vyy7lVPU0M3q_eXp6hGxT2KMAbP--C2lhmr4jIwpa5UIKtUZGwAvIBVC2QTZjvAcArSV_TzYoo0yCYiNyNZ5-z2YLbH3X32KH0cfMd9mTH0J_kH15EbK6it5mj6EfMF0NOm89dkMW7_wTBgxZ3_rbvsGuCb1dDBg_kHVXtRE_ruYWuTo9-TH-nF9-nZyNDy9zK2RBc1rKRlgNVCpe69KVhUTLalaBElyV4GpOQWpR1lYJVjkOshSFk0lX4FzFt8ju0jdl-znHOJiZjxbbtuqwn0ejqGZKlsV_QVoWIFOkBH5agjb0MQZ05jH4WRUWhoL5U7ZJZZuXshO7szKd1zNs3shVuwnYXwLPvsXFv53M-fTbq2W-_PBxwF9_P6rwYArFlTQ304kBdnw9OdJH5oL_Bnmel0U</recordid><startdate>20020801</startdate><enddate>20020801</enddate><creator>Seiwa, Chika</creator><creator>Kojima-Aikawa, Kyoko</creator><creator>Matsumoto, Isamu</creator><creator>Asou, Hiroaki</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7X8</scope></search><sort><creationdate>20020801</creationdate><title>CNS myelinogenesis in vitro: Myelin basic protein deficient shiverer oligodendrocytes</title><author>Seiwa, Chika ; Kojima-Aikawa, Kyoko ; Matsumoto, Isamu ; Asou, Hiroaki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4561-185d4c901573b98f865ec2b2a0743780fb3105948bc742af305846f5a0770ffa3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Activating Transcription Factor 2</topic><topic>Animals</topic><topic>Axons - metabolism</topic><topic>Cell Differentiation</topic><topic>Central Nervous System - growth & development</topic><topic>Coculture Techniques</topic><topic>cyclic AMP</topic><topic>Cyclic AMP - metabolism</topic><topic>Cyclic AMP - pharmacology</topic><topic>Cyclic AMP Response Element-Binding Protein - metabolism</topic><topic>differentiation</topic><topic>Female</topic><topic>Fibroblast Growth Factor 2 - pharmacology</topic><topic>Ganglia, Spinal - growth & development</topic><topic>Ganglia, Spinal - metabolism</topic><topic>Immunoblotting</topic><topic>Immunohistochemistry</topic><topic>Male</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Mice, Neurologic Mutants</topic><topic>Myelin Basic Protein - genetics</topic><topic>Myelin Sheath - metabolism</topic><topic>myelin-associated glycoprotein</topic><topic>Myelin-Associated Glycoprotein - metabolism</topic><topic>Oligodendroglia - metabolism</topic><topic>Platelet-Derived Growth Factor - pharmacology</topic><topic>Reverse Transcriptase Polymerase Chain Reaction</topic><topic>shiverer oligodendrocyte</topic><topic>Signal Transduction</topic><topic>transcription factor ATF-2</topic><topic>Transcription Factors - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Seiwa, Chika</creatorcontrib><creatorcontrib>Kojima-Aikawa, Kyoko</creatorcontrib><creatorcontrib>Matsumoto, Isamu</creatorcontrib><creatorcontrib>Asou, Hiroaki</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of neuroscience research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Seiwa, Chika</au><au>Kojima-Aikawa, Kyoko</au><au>Matsumoto, Isamu</au><au>Asou, Hiroaki</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>CNS myelinogenesis in vitro: Myelin basic protein deficient shiverer oligodendrocytes</atitle><jtitle>Journal of neuroscience research</jtitle><addtitle>J. Neurosci. Res</addtitle><date>2002-08-01</date><risdate>2002</risdate><volume>69</volume><issue>3</issue><spage>305</spage><epage>317</epage><pages>305-317</pages><issn>0360-4012</issn><eissn>1097-4547</eissn><abstract>The shiverer mutant mouse is an autosomal recessive mutant characterized by incomplete myelin sheath formation in the central nervous system (CNS). Such mice contain a deletion in the MBP gene, do not produce MBP proteins, and have little or no compact myelin in the CNS. To investigate the myelin sheath formation in shiverer mutant mice resulting from the absence of compact myelin, firstly we developed new methods for generating oligodendrocyte precursor cells (OPCs) from an E17 mouse brain, and examined homozygous shiverer (shi/shi) OPCs with respect to myelinogenesis in vitro. After treatment of shi/shi OPCs in vitro with PDGF or bFGF, proliferation of shi/shi OPCs was enhanced similar to that observed in wild‐type OPCs. The majority of cells from the shiverer mutant mouse, however, remained as A2B5‐immunoreactive early OPCs. To determine which molecular events affect the differentiation of shi/shi OPCs, we determined the signaling pathway that could be responsible for activating myelin sheath‐specific proteins. We found that the developmental schedule of shi/shi OPCs in vitro was accelerated by the addition of cyclic AMP analogs, dibutyryl cAMP (dbcAMP). Treatment of shi/shi OPCs with dbcAMP had significant effect on the differentiation of OPCs that became MAG‐expressing oligodendrocytes. To further determine the possible mechanism involved in the activation of MAG by dbcAMP, we examined the cAMP‐dependent signaling cascades. The activation of JNK was markedly stimulated by treatment with dbcAMP, and the phosphorylation of transcription factor ATF‐2 was also stimulated by dbcAMP. We demonstrated that the MAG‐positive shi/shi oligodendrocytes extend processes around axons and finally covered the axon, this was clearly observed by immunocytochemistry of shi/shi oligodendrocyte‐DRG cocultures. These results suggest that ATF‐2 coupled to specific signal transduction cascades plays an important regulatory role in MAG expression at a specific stage of shi/shi oligodendrocyte differentiation, and OPCs grow to become myelin‐forming cells with numerous cell processes that wraps around an axon to form a thin myelin sheath. © 2002 Wiley‐Liss, Inc.</abstract><cop>New York</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>12125072</pmid><doi>10.1002/jnr.10291</doi><tpages>13</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0360-4012 |
ispartof | Journal of neuroscience research, 2002-08, Vol.69 (3), p.305-317 |
issn | 0360-4012 1097-4547 |
language | eng |
recordid | cdi_proquest_miscellaneous_71927586 |
source | Wiley-Blackwell Read & Publish Collection |
subjects | Activating Transcription Factor 2 Animals Axons - metabolism Cell Differentiation Central Nervous System - growth & development Coculture Techniques cyclic AMP Cyclic AMP - metabolism Cyclic AMP - pharmacology Cyclic AMP Response Element-Binding Protein - metabolism differentiation Female Fibroblast Growth Factor 2 - pharmacology Ganglia, Spinal - growth & development Ganglia, Spinal - metabolism Immunoblotting Immunohistochemistry Male Mice Mice, Inbred C57BL Mice, Neurologic Mutants Myelin Basic Protein - genetics Myelin Sheath - metabolism myelin-associated glycoprotein Myelin-Associated Glycoprotein - metabolism Oligodendroglia - metabolism Platelet-Derived Growth Factor - pharmacology Reverse Transcriptase Polymerase Chain Reaction shiverer oligodendrocyte Signal Transduction transcription factor ATF-2 Transcription Factors - metabolism |
title | CNS myelinogenesis in vitro: Myelin basic protein deficient shiverer oligodendrocytes |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T05%3A21%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=CNS%20myelinogenesis%20in%20vitro:%20Myelin%20basic%20protein%20deficient%20shiverer%20oligodendrocytes&rft.jtitle=Journal%20of%20neuroscience%20research&rft.au=Seiwa,%20Chika&rft.date=2002-08-01&rft.volume=69&rft.issue=3&rft.spage=305&rft.epage=317&rft.pages=305-317&rft.issn=0360-4012&rft.eissn=1097-4547&rft_id=info:doi/10.1002/jnr.10291&rft_dat=%3Cproquest_cross%3E71927586%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4561-185d4c901573b98f865ec2b2a0743780fb3105948bc742af305846f5a0770ffa3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=18605561&rft_id=info:pmid/12125072&rfr_iscdi=true |